Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase Injection vs PNA for Dupuytren's Disease
NCT03000114Phase 4Unknown
- Sponsor
- University of Calgary
- Start
- Jan 2016
- Primary completion
- Jan 2021
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of collagenase clostridium histolyticum in Dupuytren's contracture (2 arms), sponsored by University of Calgary. Primary endpoint: Contracture Recurrence at 5 years. Status: unknown.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on NCT03000114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03000114.